Irritable Bowel Syndrome (IBS) Market Report

Europe Irritable Bowel Syndrome (IBS) Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 22, 2020
  • PAGES：203
  • REPORT CODE：GMM579498
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

    The Irritable Bowel Syndrome (IBS) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.1% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Irritable Bowel Syndrome (IBS) Market Segmentations:

    By Player:

    • Astellas Pharmaceuticals

    • Valeant Pharmaceuticals

    • IM HealthScience

    • McNeil Consumer Healthcare

    • Sebela Pharmaceuticals

    • Takeda

    • Sucampo Pharmaceuticals

    • Allergan

    By Type:

    • IBS-D Drug

    • IBS-C Drug

    • Other

    By End-User:

    • Women

    • Men

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Irritable Bowel Syndrome (IBS) Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of IBS-D Drug from 2014 to 2026

    • 1.3.2 Europe Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of IBS-C Drug from 2014 to 2026

    • 1.3.3 Europe Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Women from 2014 to 2026

    • 1.4.2 Europe Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Men from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Irritable Bowel Syndrome (IBS) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Irritable Bowel Syndrome (IBS) by Major Types

      • 3.4.1 Market Size and Growth Rate of IBS-D Drug

      • 3.4.2 Market Size and Growth Rate of IBS-C Drug

      • 3.4.3 Market Size and Growth Rate of Other

    4 Segmentation of Irritable Bowel Syndrome (IBS) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Irritable Bowel Syndrome (IBS) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Women for Construction

      • 4.4.2 Market Size and Growth Rate of Men for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Irritable Bowel Syndrome (IBS) Production Analysis by Top Regions

    • 5.2 Europe Irritable Bowel Syndrome (IBS) Consumption Analysis by Top Regions

    • 5.3 Europe Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

      • 5.3.3 France Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    6 Product Circulation of Irritable Bowel Syndrome (IBS) Market among Top Countries

    • 6.1 Top 5 Export Countries in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 7.1 Germany Irritable Bowel Syndrome (IBS) Landscape Analysis by Major Types

    • 7.2 Germany Irritable Bowel Syndrome (IBS) Landscape Analysis by Major End-Users

    8. UK Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 8.1 UK Irritable Bowel Syndrome (IBS) Landscape Analysis by Major Types

    • 8.2 UK Irritable Bowel Syndrome (IBS) Landscape Analysis by Major End-Users

    9. France Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 9.1 France Irritable Bowel Syndrome (IBS) Landscape Analysis by Major Types

    • 9.2 France Irritable Bowel Syndrome (IBS) Landscape Analysis by Major End-Users

    10. Italy Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 10.1 Italy Irritable Bowel Syndrome (IBS) Landscape Analysis by Major Types

    • 10.2 Italy Irritable Bowel Syndrome (IBS) Landscape Analysis by Major End-Users

    11. Spain Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 11.1 Spain Irritable Bowel Syndrome (IBS) Landscape Analysis by Major Types

    • 11.2 Spain Irritable Bowel Syndrome (IBS) Landscape Analysis by Major End-Users

    12. Poland Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 12.1 Poland Irritable Bowel Syndrome (IBS) Landscape Analysis by Major Types

    • 12.2 Poland Irritable Bowel Syndrome (IBS) Landscape Analysis by Major End-Users

    13. Russia Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 13.1 Russia Irritable Bowel Syndrome (IBS) Landscape Analysis by Major Types

    • 13.2 Russia Irritable Bowel Syndrome (IBS) Landscape Analysis by Major End-Users

    14. Switzerland Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 14.1 Switzerland Irritable Bowel Syndrome (IBS) Landscape Analysis by Major Types

    • 14.2 Switzerland Irritable Bowel Syndrome (IBS) Landscape Analysis by Major End-Users

    15. Turkey Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 15.1 Turkey Irritable Bowel Syndrome (IBS) Landscape Analysis by Major Types

    • 15.2 Turkey Irritable Bowel Syndrome (IBS) Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Irritable Bowel Syndrome (IBS) Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Irritable Bowel Syndrome (IBS) Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Irritable Bowel Syndrome (IBS) Landscape Analysis by Top Countries

      • 16.3.1 Denmark Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 16.3.2 Finland Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 16.3.3 Norway Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 16.3.4 Sweden Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 16.3.6 Iceland Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Irritable Bowel Syndrome (IBS) Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Irritable Bowel Syndrome (IBS) Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Irritable Bowel Syndrome (IBS) Landscape Analysis by Top Countries

      • 17.3.1 Belgium Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 17.3.2 Netherlands Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 17.3.3 Luxembourg Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Irritable Bowel Syndrome (IBS) Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Irritable Bowel Syndrome (IBS) Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Irritable Bowel Syndrome (IBS) Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Irritable Bowel Syndrome (IBS) Landscape Analysis by Top Countries

      • 18.3.1 Estonia Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 18.3.2 Latvia Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

      • 18.3.3 Lithuania Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Astellas Pharmaceuticals

      • 19.1.1 Astellas Pharmaceuticals Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Valeant Pharmaceuticals

      • 19.2.1 Valeant Pharmaceuticals Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 IM HealthScience

      • 19.3.1 IM HealthScience Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 McNeil Consumer Healthcare

      • 19.4.1 McNeil Consumer Healthcare Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Sebela Pharmaceuticals

      • 19.5.1 Sebela Pharmaceuticals Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Takeda

      • 19.6.1 Takeda Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Sucampo Pharmaceuticals

      • 19.7.1 Sucampo Pharmaceuticals Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Allergan

      • 19.8.1 Allergan Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    The List of Tables and Figures (Totals 115 Figures and 173 Tables)

    • Figure Product Picture

    • Figure Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of IBS-D Drug Market, 2015 - 2026 (USD Million)

    • Figure Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of IBS-C Drug Market, 2015 - 2026 (USD Million)

    • Figure Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Other Market, 2015 - 2026 (USD Million)

    • Figure Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Women from 2014 to 2026

    • Figure Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Men from 2014 to 2026

    • Figure Germany Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure UK Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure France Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Irritable Bowel Syndrome (IBS) Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Irritable Bowel Syndrome (IBS) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Irritable Bowel Syndrome (IBS)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Irritable Bowel Syndrome (IBS) by Different Types from 2014 to 2026

    • Table Consumption Share of Irritable Bowel Syndrome (IBS) by Different Types from 2014 to 2026

    • Figure Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of IBS-D Drug Market, 2015 - 2026 (USD Million)

    • Figure Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of IBS-C Drug Market, 2015 - 2026 (USD Million)

    • Figure Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Other Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Irritable Bowel Syndrome (IBS) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Irritable Bowel Syndrome (IBS) by Different End-Users from 2014 to 2026

    • Figure Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Women from 2014 to 2026

    • Figure Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Men from 2014 to 2026

    • Table Europe Irritable Bowel Syndrome (IBS) Production by Major Regions

    • Table Europe Irritable Bowel Syndrome (IBS) Production Share by Major Regions

    • Figure Europe Irritable Bowel Syndrome (IBS) Production Share by Major Countries and Regions in 2014

    • Table Europe Irritable Bowel Syndrome (IBS) Consumption by Major Regions

    • Table Europe Irritable Bowel Syndrome (IBS) Consumption Share by Major Regions

    • Table Germany Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table UK Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table France Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table Italy Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table Spain Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table Poland Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table Russia Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table Switzerland Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table Turkey Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Irritable Bowel Syndrome (IBS) Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Irritable Bowel Syndrome (IBS) Consumption by Types from 2014 to 2026

    • Table Germany Irritable Bowel Syndrome (IBS) Consumption Share by Types from 2014 to 2026

    • Table Germany Irritable Bowel Syndrome (IBS) Consumption by End-Users from 2014 to 2026

    • Table Germany Irritable Bowel Syndrome (IBS) Consumption Share by End-Users from 2014 to 2026

    • Table UK Irritable Bowel Syndrome (IBS) Consumption by Types from 2014 to 2026

    • Table UK Irritable Bowel Syndrome (IBS) Consumption Share by Types from 2014 to 2026

    • Table UK Irritable Bowel Syndrome (IBS) Consumption by End-Users from 2014 to 2026

    • Table UK Irritable Bowel Syndrome (IBS) Consumption Share by End-Users from 2014 to 2026

    • Table France Irritable Bowel Syndrome (IBS) Consumption by Types from 2014 to 2026

    • Table France Irritable Bowel Syndrome (IBS) Consumption Share by Types from 2014 to 2026

    • Table France Irritable Bowel Syndrome (IBS) Consumption by End-Users from 2014 to 2026

    • Table France Irritable Bowel Syndrome (IBS) Consumption Share by End-Users from 2014 to 2026

    • Table Italy Irritable Bowel Syndrome (IBS) Consumption by Types from 2014 to 2026

    • Table Italy Irritable Bowel Syndrome (IBS) Consumption Share by Types from 2014 to 2026

    • Table Italy Irritable Bowel Syndrome (IBS) Consumption by End-Users from 2014 to 2026

    • Table Italy Irritable Bowel Syndrome (IBS) Consumption Share by End-Users from 2014 to 2026

    • Table Spain Irritable Bowel Syndrome (IBS) Consumption by Types from 2014 to 2026

    • Table Spain Irritable Bowel Syndrome (IBS) Consumption Share by Types from 2014 to 2026

    • Table Spain Irritable Bowel Syndrome (IBS) Consumption by End-Users from 2014 to 2026

    • Table Spain Irritable Bowel Syndrome (IBS) Consumption Share by End-Users from 2014 to 2026

    • Table Poland Irritable Bowel Syndrome (IBS) Consumption by Types from 2014 to 2026

    • Table Poland Irritable Bowel Syndrome (IBS) Consumption Share by Types from 2014 to 2026

    • Table Poland Irritable Bowel Syndrome (IBS) Consumption by End-Users from 2014 to 2026

    • Table Poland Irritable Bowel Syndrome (IBS) Consumption Share by End-Users from 2014 to 2026

    • Table Russia Irritable Bowel Syndrome (IBS) Consumption by Types from 2014 to 2026

    • Table Russia Irritable Bowel Syndrome (IBS) Consumption Share by Types from 2014 to 2026

    • Table Russia Irritable Bowel Syndrome (IBS) Consumption by End-Users from 2014 to 2026

    • Table Russia Irritable Bowel Syndrome (IBS) Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Irritable Bowel Syndrome (IBS) Consumption by Types from 2014 to 2026

    • Table Switzerland Irritable Bowel Syndrome (IBS) Consumption Share by Types from 2014 to 2026

    • Table Switzerland Irritable Bowel Syndrome (IBS) Consumption by End-Users from 2014 to 2026

    • Table Switzerland Irritable Bowel Syndrome (IBS) Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Irritable Bowel Syndrome (IBS) Consumption by Types from 2014 to 2026

    • Table Turkey Irritable Bowel Syndrome (IBS) Consumption Share by Types from 2014 to 2026

    • Table Turkey Irritable Bowel Syndrome (IBS) Consumption by End-Users from 2014 to 2026

    • Table Turkey Irritable Bowel Syndrome (IBS) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Irritable Bowel Syndrome (IBS) Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Irritable Bowel Syndrome (IBS) Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Irritable Bowel Syndrome (IBS) Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Irritable Bowel Syndrome (IBS) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Irritable Bowel Syndrome (IBS) Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Irritable Bowel Syndrome (IBS) Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Irritable Bowel Syndrome (IBS) Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Irritable Bowel Syndrome (IBS) Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Irritable Bowel Syndrome (IBS) Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Irritable Bowel Syndrome (IBS) Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Irritable Bowel Syndrome (IBS) Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Irritable Bowel Syndrome (IBS) Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Irritable Bowel Syndrome (IBS) Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Irritable Bowel Syndrome (IBS) Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Irritable Bowel Syndrome (IBS) Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Irritable Bowel Syndrome (IBS) Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Irritable Bowel Syndrome (IBS) Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Irritable Bowel Syndrome (IBS) Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Irritable Bowel Syndrome (IBS) Market Volume and Growth Rate from 2014 to 2026

    • Table Astellas Pharmaceuticals Profiles

    • Table Astellas Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Astellas Pharmaceuticals Product benchmarking

    • Table Astellas Pharmaceuticals Strategic initiatives

    • Table Astellas Pharmaceuticals SWOT analysis

    • Table Valeant Pharmaceuticals Profiles

    • Table Valeant Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Valeant Pharmaceuticals Product benchmarking

    • Table Valeant Pharmaceuticals Strategic initiatives

    • Table Valeant Pharmaceuticals SWOT analysis

    • Table IM HealthScience Profiles

    • Table IM HealthScience Production, Value, Price, Gross Margin 2014-2019

    • Table IM HealthScience Product benchmarking

    • Table IM HealthScience Strategic initiatives

    • Table IM HealthScience SWOT analysis

    • Table McNeil Consumer Healthcare Profiles

    • Table McNeil Consumer Healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table McNeil Consumer Healthcare Product benchmarking

    • Table McNeil Consumer Healthcare Strategic initiatives

    • Table McNeil Consumer Healthcare SWOT analysis

    • Table Sebela Pharmaceuticals Profiles

    • Table Sebela Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Sebela Pharmaceuticals Product benchmarking

    • Table Sebela Pharmaceuticals Strategic initiatives

    • Table Sebela Pharmaceuticals SWOT analysis

    • Table Takeda Profiles

    • Table Takeda Production, Value, Price, Gross Margin 2014-2019

    • Table Takeda Product benchmarking

    • Table Takeda Strategic initiatives

    • Table Takeda SWOT analysis

    • Table Sucampo Pharmaceuticals Profiles

    • Table Sucampo Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Sucampo Pharmaceuticals Product benchmarking

    • Table Sucampo Pharmaceuticals Strategic initiatives

    • Table Sucampo Pharmaceuticals SWOT analysis

    • Table Allergan Profiles

    • Table Allergan Production, Value, Price, Gross Margin 2014-2019

    • Table Allergan Product benchmarking

    • Table Allergan Strategic initiatives

    • Table Allergan SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US